In vivo imaging of chronic active lesions in multiple sclerosis
- PMID: 32965168
- PMCID: PMC8978472
- DOI: 10.1177/1352458520958589
In vivo imaging of chronic active lesions in multiple sclerosis
Abstract
New clinical activity in multiple sclerosis (MS) is often accompanied by acute inflammation which subsides. However, there is growing evidence that a substantial proportion of lesions remain active well beyond the acute phase. Chronic active lesions are most frequently found in progressive MS and are characterised by a border of inflammation associated with iron-enriched cells, leading to ongoing tissue injury. Identifying imaging markers for chronic active lesions in vivo are thus a major research goal. We reviewed the literature on imaging of chronic active lesion in MS, focussing on 'slowly expanding lesions' (SELs), detected by volumetric longitudinal magnetic resonance imaging (MRI) and 'rim-positive' lesions, identified by susceptibility iron-sensitive MRI. Both SELs and rim-positive lesions have been found to be prognostically relevant to future disability. Little is known about the co-occurrence of rims around SELs and their inter-relationship with other emerging techniques such as dynamic contrast enhancement (DCE) and positron emission tomography (PET).
Keywords: Multiple sclerosis; chronic active lesions; imaging; magnetic resonance imaging; positron emission tomography.
Conflict of interest statement
Figures
References
-
- Van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26(1): 2–10. - PubMed
-
- Bö L, Mörk S, Kong PA, et al.. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994; 51(2): 135–146. - PubMed
-
- Brück W, Porada P, Poser S, et al.. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38(5): 788–796. - PubMed
-
- Kuhlmann T, Ludwin S, Prat A, et al.. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 2017; 133(1): 13–24. - PubMed
-
- Prineas JW, Parratt JDE. Oligodendrocytes and the early multiple sclerosis lesion. Ann Neurol 2012; 72(1): 18–31. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
